The group has also received the US drug regulator's nod to market anti-bacterial drug, linezolid BS B2B Bureau | Ahmedabad February 27, 2017 Last... ...http://www.business-standard.com/content/b2b-pharma/zydus-receives-us-fda-approval-for-anti-viral-drug-oseltamivir-117022700495_1.html
The market is quite sluggish today with investors largely treading cautiously, looking ahead to the US President Donald Trump's speech on Tuesday,... ...http://www.sify.com/finance/sensex-nifty-caught-in-tight-band-amid-stock-specific-activity-news-sensex-rc1mMwaiejbhg.html
Indian companies have made acquisitions of $1 billion so far in January Outbound acquisitions by Indian companies have seen a surge in the first... ...http://www.rediff.com/money/report/year-begins-with-a-bang-for-outbound-ma-deals/20170131.htm
One reason Japan is betting highly on Indian pharma is that these companies have strong cash flows, low leverage and high debt capacity for medium... ...http://www.rediff.com/money/report/why-japan-is-betting-big-on-indian-pharma-cos/20170126.htm
Posted by Equitymaster Global markets ended the week on a dull note with most of the markets ending flat or in the negative territory. Brazil's and... ...http://www.equitymaster.com/tm/tm.asp?date=1/20/2017&title=Global-Markets-Continues-to-be-Volatile
The company was formed way back in...